×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
(MP01-03) The association of matrix metalloproteinase 9 genotypes on renal cell carcinoma risks in mid-Taiwan
01-10
(MP01-02) Testosterone breakthrough rates during androgen deprivation therapy for castration sensitive prostate cancer
01-10
(MP01-01) MRI-US fusion prostate biopsy in diagnosis of prostate cancer: A preliminary experience of 3 years
01-10
PD03-6: Age-related differences in risk factors and clinical presentations of fournier's gangrene
01-10
PD03-5: The impact of COVID-19 on the management of fournier's gangrene: What have we learned?
01-10
PD03-4: Risk factors and management of fournier's gangrene: An 18-year retrospective study
01-10
PD03-3: A pilot study for combination of urine biomarkers and skin sympathetic nerve activity in improving diagnostic accuracy for urge urinary incontinence
01-10
PD03-2: Developing dual AI models using non-invasive clinical parameters to aid in male bladder outlet obstruction diagnosis and minimize the need for invasive video-urodynamic studies
01-10
PD03-1: Low-intensity shock wave therapy in treating bladder overactivity induced by metabolic syndrome and hormonal deficiency: A rat model study
01-10
PD02-06: To evaluate the effect of Cinnamaldehyde on the cardiac and renal pathology in a rat model of cardiorenal syndrome type 1.
01-10
PD02-05: Early cystography before catheter removal after robot assisted radical prostatectomy
01-10
PD02-04: Immediate assessment of spermatogenesis at testicular biopsy for azoospermic males using touch print smear
01-10
PD02-03: Navigating the obesity paradox in bladder cancer prognosis – insights from the Taiwan national health insurance system database
01-10
PD02-02: Lenvatinib enhances Cisplatin sensitivity, induces apoptosis and inhibits metastasis in bladder cancer cells through inactivation of EGFR/ERK/P-38/NF-κB signaling
01-10
PD02-01: External validation of a new Taiwanese prostate cancer risk calculator within another medical centre
01-10
PD01-06: Retroperitoneal laparoscopic adrenalectomy for large adrenal tumors—analysis of tumor size and adverse events: A retrospective single-center study
01-10
PD01-05: ChatGPT-4 as a tool for patient education: artificial intelligence and urological cancer-related queries
01-10
PD01-04: Study on the pro-tumor function of UBE2C gene in metastatic prostate cancer and tts potential as a therapeutic marker
01-10
PD01-03: Neoadjuvant therapy in initially inoperable upper tract urothelial carcinoma – a comparative study with adjuvant strategies
01-10
PD01-02: Knockdown of EPS8 expression may attenuate disease progression in enzalutamide-resistant prostate cancer
01-10
PD01-01: Safety and efficacy of enzalutamide by ereatment duration in the Asian subgroup from ARCHES: A post hoc analysis
01-10
PD03-6: Urinary stone analysis and clinical characteristics of 630 patients in Taiwan
2023-07-05
PD03-5: Glycated Tamm-Horsfall protein of diabetes patients decrease the function on crystal aggregation inhibition
2023-07-05
PD03-4: Inflammatory cytokines enhance osteogenic proteins expression in renal tubular cells
2023-07-05
<
9
10
11
12
13
14
15
16
17
18
>
/ 121